News Archive
Date: 10/12/2020
Survival rates for women with inflammatory breast cancer have nearly doubled, but analysis shows an ongoing disparity between the survival rates of white patients and Black patients.
Date: 10/07/2020
The Ovarian Cancer Initiative at Michigan Medicine has received a generous bequest from Beth J. Johnson. It is the culmination of her dedicated efforts and extensive volunteer work for the initiative
Date: 10/01/2020
With a new $7.2 million grant from the National Cancer Institute, Rogel Cancer Center researchers and their national collaborators will test whether blocking inflammatory processes could protect cells and potentially prevent some cancers.
Date: 09/28/2020
Researchers at the Rogel Cancer Center have developed a new diagnostic approach using artificial intelligence that aims to do exactly that — and with greater than 90% accuracy
Date: 09/28/2020
By distilling information from hundreds of data sources, including published genome-wide association studies (GWAS) and meta-analyses, Rogel Cancer Center researchers generated polygenic risk scores (PRS) for 35 common types of cancer.
Date: 09/25/2020
A new expressive writing tool called Making Meaning allows people to put their thoughts and feelings into words to help relieve stress and anxiety.
Date: 09/24/2020
Researchers at the Medicine C.S Mott Children’s Hospital and the U-M Rogel Cancer Center have been breaking new ground in understanding and treating childhood brain cancers, including some of the most serious and aggressive types of tumors.
Date: 09/23/2020
Postdoctoral training is to bench scientists what residency programs are to medical students — a period of mentored apprenticeship to bridge the gap between one’s student years and an independent career.
Date: 09/20/2020
A new inhibitor designed to target what’s been called an “undruggable” genetic mutation showed promising activity against advanced cancers with this mutation.
Date: 09/18/2020
The new report from the American Association for Cancer Research (AACR) highlights the impact of cancer health disparities and calls for transformative research, collaboration and committed funding to ensure research-driven advances benefit everyone.